Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 May 1;46(5):e110-e111.
doi: 10.2337/dc22-2491.

Comment on Duarte et al. Systematic Review and Network Meta-analysis of Neurostimulation for Painful Diabetic Neuropathy. Diabetes Care 2022;45:2466-2475

Ashwini D Sharan  1   2 , John A Hatheway  3 , Melissa Murphy  4 , Tammy Dann  5 , Michael A Fishman  6 , Xander Zuidema  7 , Jan H M van Zundert  7 , Maddie LaRue  1 , Rachel Slangen  1
Affiliations
Comment

Comment on Duarte et al. Systematic Review and Network Meta-analysis of Neurostimulation for Painful Diabetic Neuropathy. Diabetes Care 2022;45:2466-2475

Ashwini D Sharan et al. Diabetes Care. .
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Duarte RV, Nevitt S, Copley S, et al. . Systematic review and network meta-analysis of neurostimulation for painful diabetic neuropathy. Diabetes Care 2022;45:2466–2475 - PubMed
    1. Slangen R, Schaper NC, Faber CG, et al. . Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care 2014;37:3016–3024 - PubMed
    1. De Vos CC, Meier K, Zaalberg PB, et al. . Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain 2014;155:2426–2431 - PubMed
    1. Petersen EA, Stauss TG, Scowcroft JA, et al. . Effect of high-frequency (10-kHz) spinal cord stimulation in patients with painful diabetic neuropathy: a randomized clinical trial. JAMA Neurol 2021;78:687–698 - PMC - PubMed
    1. U.S. Food and Drug Administration . FDA summary of safety and effectiveness data, P130022 S039. 16 July 2021. Accessed 15 December 2022. Available from https://www.accessdata.fda.gov/cdrh_docs/pdf13/P130022S039B.pdf